Is #MRI ready to replace biopsy during active surveillance for #prostate cancer? Check out our Review on European Radiology! link.springer.com/article/10.100… Adriano Dias 𝐒𝐮𝐧𝐠𝐦𝐢𝐧 𝐖𝐨𝐨, 𝐌𝐃 𝐏𝐡𝐃 Riccardo Leni Pawel Rajwa Veeru Kasi Sangeet Ghai Masoom Haider Giorgio Gandaglia Rossano Girometti Francesco Giganti ESUR Junior Network

🛎️ Check out the latest European Radiology Review on the role of #ProstateMRI during Active Surveillance. Special thanks to Giorgio Brembilla 𝐒𝐮𝐧𝐠𝐦𝐢𝐧 𝐖𝐨𝐨, 𝐌𝐃 𝐏𝐡𝐃! 🤝 Great teamwork with Riccardo Leni Pawel Rajwa Veeru Kasi Sangeet Ghai Masoom Haider Giorgio Gandaglia Thanks Rossano Girometti Francesco Giganti!

Integrating MRI in prostate cancer screening pathways reduces the number of unnecessary biopsies and the overdiagnosis of insignificant cancers, while maintaining clinically significant prostate cancer detection as compared with PSA-only screening. ja.ma/4crWDKX

The efficacy and safety of metastasis-directed therapy in patients with #ProstateCancer: a systematic review and meta-analysis of prospective studies. #BeyondTheAbstract on UroToday > bit.ly/4ezO6r5 Marcin Miszczyk, Shahrokh F. Shariat Pawel Rajwa European Urology

➡️#Rakprostaty wciąż stanowi istotne wyzwanie kliniczne. Możemy jeszcze wiele zrobić, by wydłużyć życie chorych i poprawić jego jakość - przekonuje dr hab. Paweł Rajwa Pawel Rajwa z Śląski Uniwersytet Medyczny w Katowicach 🏅laureat 2⃣. miejsca w konkursie #SupertalentywMedycynie 2024 tiny.pl/d4r8x

#ARANOTE positive #darolutamide Ph III trial in mHSPC OncoAlert ESMO - Eur. Oncology #ESMO24 neal shore Neeraj Agarwal, MD, FASCO businesswire.com/news/home/2024…®-darolutamide-from-Phase-III-trial-in-men-with-metastatic-hormone-sensitive-prostate-cancer-mHSPC

As good as I've seen. Should be mandatory reading for all PCP's and urologists who screen for PrCa Prostate-specific antigen screening for prostate cancer: Diagnostic pe... sciencedirect.com/science/articl… Michael Leapman Preston Sprenkle, MD

Great to reflect on PSA and its enormous impact. Clinicians should take note that we still leave much on the table with this perennial all-star biomarker. Simple low-cost information can be added from free % PSA, PSA density, baseline values.

Does bilateral mastectomy for unilateral breast cancer reduce breast cancer mortality? No. A study of 661,270 women shows bilateral mastectomy lowers contralateral cancer risk but not mortality: effective prevention but no survival benefit. OncoAlert #cancer #oncology JAMA Oncology

PSMA-PET by PROMISE (PPP) outperformed established risk scores, proving effective in high/low-risk stratification in prostate cancer. Ongoing validation continues. The Lancet Oncology Ken Herrmann Viktor Grünwald doi.org/10.1016/S1470-…

SOLAR Phase 2 trial: multimodal therapy without long-term castration ➡️de novo oligometastatic PCa ➡️RP or RT to the primary + MDT (SBRT) + Intensified systemic therapy for 6 months (ADT+Apa+Abi) ➡️Primary endpoint: percentage of patients with testosterone ≥150 and undetectable

TP-Tbx and TR-Tbx prostate biopsy have🟰csPca detection rates and🟰complication rates. #TPbiopsies can be safely performed without antibiotics, potentially reducing antibiotic resistance. pubmed.ncbi.nlm.nih.gov/39095298/

Targeting Androgen Receptor Alterations in Metastatic Prostate Cancer Pawel Rajwa European Association of Urology (EAU) OncoAlert sciencedirect.com/science/articl…

🚨Do not miss latest findings on TP vs TR MRI-🎯Bx for #prostatecancer detection 👇🏻 European Urology Oncology pubmed.ncbi.nlm.nih.gov/39095298/ European Association of Urology (EAU) EAU Young Academics

The efficacy and safety of metastasis-directed therapy in patients with #ProstateCancer: a systematic review and meta-analysis of prospective studies. #BeyondTheAbstract on UroToday > bit.ly/4ezO6r5 Marcin Miszczyk, Shahrokh F. Shariat Pawel Rajwa European Urology

As I prepare to embark on the next chapter of my European Association of Urology (EAU) journey, I want to take a moment to express my gratitude to EAU Young Academics I have been filled with remarkable experiences, and I am immensely grateful for the support, collaboration, and friendship collected through the

The Proteogenomics of Prostate Cancer Radioresistance out on Cancer Research Communications aacrjournals.org/cancerrescommu… #ProstateCancer radioresistance☢️ remains a challenge in radiotherapy, with aggressive relapses often occurring, but the underlying molecular mechanisms are not well understood. This

Addition of ARPIs to ADT increases the risk of cardiac disorders( ie., IHD, AF, & hypertension). Each ARPI exhibits a distinct cardiovascular event profile. Selecting patients carefully & vigilant monitoring for cardiovascular issues is imperative. nature.com/articles/s4139…